a-ee85aqa.blogspot.com
Formerly Novitron International, Inc., Clinical Data, Inc. is currentlty listed on the Nasdaq Global Market under the tradinfsymbol CLDA. In 2005, the Company completed a $12 million privates placement and a number of acquisitions that significantlt alteredthe Company's breadth and depth of serviceds offered to customers. In the process, the Company migraterd from being solely a traditional diagnostics company as a provide r oflab equipment, reagents and support servicese to medium-sized physician practices to also becoming a leade in molecular and pharmacogenomics services such as genomicz (including pharmacogenomics), pharmacogenetics, proteomics, metabolomica and related sciences.
In 2007, Clinical Data acquireds EpidaurosBiotechnologie AG: - Privatelh held Epidauros Biotechnologie AG of Germany was acquired in a cash transaction valuexd at 8.75 million euros (or approximately $11.84r million). Epidauros investigates the genetic factors that influencea person'ws response to a drug and makes drug development and therapy safer, more efficienty and more predictive. The company is a worldwidee leading Pharmacogenetic Research Organizationproviding innovative, integratecd and value-added solutions to an international customer base consistiny of pharmaceutical companies, CROs and other companiews acting in the field of health Epidauros brings to Clinical Data an established portfolio of proprietaryh genetic biomarkers, expertise in genetic biomarker discovery,...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment